In one paragraphArticle in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
23 authors.
Juan AzcárateMultidisciplinary Breast Cancer Unit, Department of Pathology, Hospital Universitari Bellvitge, 08907 Barcelona, Spain.ORCID 0000-0001-6655-1874 Anna PetitMultidisciplinary Breast Cancer Unit, Department of Pathology, Hospital Universitari Bellvitge, 08907 Barcelona, Spain.
Teresa Soler-MonsóMultidisciplinary Breast Cancer Unit, Department of Pathology, Hospital Universitari Bellvitge, 08907 Barcelona, Spain.ORCID 0000-0001-5567-2590 Eugenia QuirósMultidisciplinary Breast Cancer Unit, Department of Pathology, Hospital Universitari Bellvitge, 08907 Barcelona, Spain.
Andrea VethencourtInstituto de Investigación Biomédica de Bellvitge (IDIBELL), 08908 Barcelona, Spain.ORCID 0000-0002-2747-0892 Agostina StradellaInstituto de Investigación Biomédica de Bellvitge (IDIBELL), 08908 Barcelona, Spain.
Amparo García-TejedorInstituto de Investigación Biomédica de Bellvitge (IDIBELL), 08908 Barcelona, Spain.ORCID 0000-0003-3398-0570 Maria Jesús Pla-FarnosInstituto de Investigación Biomédica de Bellvitge (IDIBELL), 08908 Barcelona, Spain.ORCID 0000-0001-7119-4031 Héctor Pérez-MonteroInstituto de Investigación Biomédica de Bellvitge (IDIBELL), 08908 Barcelona, Spain.ORCID 0000-0002-9756-5088 Anna GumàInstituto de Investigación Biomédica de Bellvitge (IDIBELL), 08908 Barcelona, Spain.
Raúl OrtegaInstituto de Investigación Biomédica de Bellvitge (IDIBELL), 08908 Barcelona, Spain.
Diana PérezMultidisciplinary Breast Cancer Unit, Department of Reparative Surgery, Hospital Universitari Bellvitge, 08907 Barcelona, Spain.
Cristina CapóMultidisciplinary Breast Cancer Unit, Department of Gynecology, Hospital de Viladecans, 08840 Barcelona, Spain.
Mar VarelaMultidisciplinary Breast Cancer Unit, Department of Pathology, Hospital Universitari Bellvitge, 08907 Barcelona, Spain.ORCID 0000-0002-2129-6336 María Del Rosario Taco-SánchezMultidisciplinary Breast Cancer Unit, Department of Pathology, Hospital Universitari Bellvitge, 08907 Barcelona, Spain.
Esther GuerraMultidisciplinary Breast Cancer Unit, Department of Pathology, Hospital Universitari Bellvitge, 08907 Barcelona, Spain.
Jan Bosch-SchipsMultidisciplinary Breast Cancer Unit, Department of Pathology, Hospital Universitari Bellvitge, 08907 Barcelona, Spain.ORCID 0009-0009-7888-6810 August VidalMultidisciplinary Breast Cancer Unit, Department of Pathology, Hospital Universitari Bellvitge, 08907 Barcelona, Spain.ORCID 0000-0001-5727-2099 Evelyn Martínez-PérezInstituto de Investigación Biomédica de Bellvitge (IDIBELL), 08908 Barcelona, Spain.ORCID 0000-0002-3463-5333 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
breast cancerheterogeneityintraepithelial infiltrateluminal B breast cancerneoadjuvant chemotherapyplasma cellspredictive biomarkerstumor-infiltrating lymphocytes (TILs)tumor microenvironment
Identifiers
PMID42449610
PMCPMC13360514
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390